Pharmacy Ingredient Supplier Pays $22M For Reporting Inflated Wholesale Prices

(November 8, 2019, 2:12 PM EST) -- WASHINGTON, D.C. — The U.S. Justice Department on Nov. 7 announced that Fagron Holding USA LLC agreed to pay $22.05 million to resolve allegations that subsidiary Freedom Pharmaceuticals Inc. reported inflated...
To view the full article, register now.